Artificial Intelligence in Predictive Toxicology Market 2024-2033: Analysis, Trends & Forecast

The artificial intelligence (AI) in predictive toxicology market size has grown exponentially in recent years. It will grow from $0.38 billion in 2023 to $0.50 billion in 2024 at a compound annual growth rate (CAGR) of 30.3%. The growth in the historic period can be attributed to increasing regulatory pressure for toxicity assessment, growing concerns about chemical safety, availability of large datasets for model training, rising costs and ethical concerns associated with animal testing, demand for faster and more cost-effective toxicity screening methods.

The artificial intelligence (AI) in predictive toxicology market size is expected to see exponential growth in the next few years. It will grow to $1.41 billion in 2028 at a compound annual growth rate (CAGR) of 29.9%. The growth in the forecast period can be attributed to emergence of explainable artificial intelligence (AI) in toxicology predictions, demand for personalized toxicity assessments, regulatory acceptance and standardization of AI-based toxicity predictions, rise in predictive toxicology outsourcing services, expansion of AI applications in drug discovery and development. Major trends in the forecast period include shift towards 3D cell culture models for toxicity testing, rise of federated learning approaches for collaborative toxicity prediction, application of generative models for predicting chemical toxicity pathways, incorporation of natural language processing for extracting toxicity data from literature, growth of virtual screening platforms for prioritizing chemical testing.

Market Overview -
Artificial intelligence (AI) in predictive toxicology refers to the use of artificial intelligence techniques to analyze biological, chemical, and environmental data to predict the potential toxicity of chemicals and compounds. It is used to expedite chemical safety assessments, predict drug toxicity, and prioritize chemicals for further testing.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=14253&type=smp

Increasing Demand For Efficient And Ethical Drug Discovery Processes Driving AI In Predictive Toxicology Market Growth
The increasing demand for efficient and ethical drug discovery processes is expected to propel the growth of artificial intelligence (AI) in predictive toxicology market going forward. Drug discovery is an intricate and dynamic process that involves the systematic exploration, synthesis, and evaluation of chemical compounds to discover potential therapeutic agents to alleviate diseases and enhance overall well-being, while efficient and ethical drug discovery processes involve leveraging advanced technologies and prioritizing responsible research practices to develop new therapeutic agents. The demand for efficient and ethical drug discovery processes is driven by rising chronic diseases, growing trend towards personalized medicine, and an increased prevalence of age-related diseases. Artificial intelligence (AI) in predictive toxicology enhances drug discovery processes by efficiently analyzing vast datasets to predict potential toxicological outcomes, thereby accelerating drug development while ensuring ethical standards are met. For instance, in June 2023, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association representing the pharmaceutical industry, the total pharmaceutical R&D expenditure in Europe accounted for $49,500 million (€44,500 million) in 2022, an increase of approximately 6.45% from $46,500 million (€42,533 million) in 2021. Therefore, the increasing demand for efficient and ethical drug discovery processes is driving the growth of the artificial intelligence (AI) in predictive toxicology market.

Competitive Landscape -
Major companies operating in the artificial intelligence (AI) in predictive toxicology market are Laboratory Corporation of America Holdings (LabCorp), Eurofins Scientific SE, Wuxi AppTec, Charles River Laboratories International, Medidata Solutions Inc., Certara Inc., Schrödinger, Merative L.P., Molecular Devices LLC, Envigo (Inotiv Inc.), Instem plc, Simulations Plus, Cyprotex, Recursion Pharmaceuticals, Exscientia PLC, BIOVIA Corporation, Lhasa Limited, Chemaxon Ltd., Insilico Medicine Inc., Algorithme Pharma, CiToxLAB, ArisGlobal, Benevolent AI, Berg Health, Cyclica Therapeutics Inc., Celsius Therapeutics, Biovista Inc., BioTeam Inc.

Key Players Driving Innovation Through Strategic Collaborations In The Pharmaceutical Industry
Major companies operating in the artificial intelligence (AI) predictive toxicology market are adopting a strategic collaboration approaches to enhance market presence and innovation. These collaborations aim to leverage AI and machine learning techniques to improve the prediction and assessment of the toxicity of chemical compounds and pharmaceuticals. For instance, in January 2024, SyntheticGestalt, a UK-based AI research and development company offering AI drug discovery solutions, partnered with Enamine, a Ukraine-based provider of chemical building blocks, screening compounds, and integrated drug discovery services, to develop a set of AI models facilitating the generation of synthetically accessible biologically active compounds, optimizing their physicochemical and ADME or Tox (Absorption, Distribution, Metabolism, and Excretion or Toxicity) properties. These models will find application in SyntheticGestalt's compound discovery endeavors, catering to both academic users and pharmaceutical companies through their services. Enamine has made its extensive Enamine REAL database, containing 38 billion molecules, available for access. SyntheticGestalt will integrate this database into its Drug Discovery Service, utilizing proprietary AI models to predict the physicochemical and ADME or Tox properties of compounds. The service will promptly suggest improved alternative compounds for those with issues.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-predictive-toxicology-global-market-report

Key Segments -
The artificial intelligence (AI) in predictive toxicology market covered in this report is segmented -
1) By Component: Solution, Services
2) By Technology: Machine Learning, Natural Language Processing, Computer Vision, Other Technologies
3) By Toxicity Endpoints: Genotoxicity, Hepatotoxicity, Neurotoxicity, Cardiotoxicity, Other Toxicity Endpoints
4) By End User: Pharmaceutical And Biotechnology Companies, Chemical And Cosmetics, Contract Research Organizations, Other End Users

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.